Becton Dickinson (BDX)EVP and Chief ISC Officer sold ~$330K
David Shan, EVP and Chief ISC Officer at Becton Dickinson, sold ~$330K of Becton Dickinson shares.
- ~$330K
- Approx. value · 1,500 sh @ $220.25
- 6,285
- Holds after · shares reported
- Traded
- Dec 5, 2024
- Filed
- Dec 6, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 5, 2024 · this disclosureInsiderOfficer sold ~$330K of BDX shares in the open market
What came next
- Dec 6, 2024Insider · 2 peopleInsiders: 2 sales (~$1.2M)
- Dec 9, 2024InsiderOfficer sold ~$140K of BDX shares in the open market
- Dec 19, 2024InsiderOfficer sold ~$634K of BDX shares in the open market
- Jan 7, 2025InsiderOfficer sold ~$185K of BDX shares in the open market
- Jan 17, 2025InsiderOfficer sold ~$141K of BDX shares in the open market
- Jan 21, 2025Insider · 2 peopleInsiders: 2 sales (~$309K)
- Feb 5, 2025FDARecall: Rotarex Atherectomy System and Instructions for Use, BD SET Rotarex: S 6 F x 110 cm, REF: 80236; S 6 F x 135 cm, REF: 80237; S 8 F x 85 cm, REF: 80238; S 8 F x…
- Feb 6, 2025FDARecall: BD Pyxis: Anesthesia Station ES, REF: 327, MedStation ES, REF: 323, MedStation ES Tower, REF: 352, CII Safe ES, REF: 1116-00, CII Safe ES Desktop PC, REF: 1156…
- Feb 10, 2025InsiderDirector purchased ~$350K of BDX shares in the open market
- Feb 12, 2025FDARecall: BD BBL TB Stain Kit K, Catalog (REF): 212522
- Feb 12, 2025InsiderDirector sold ~$160K of BDX shares in the open market
- Feb 14, 2025FDARecall: BD ChloraPrep Clear 1mL Applicators, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Patient Preoperative Skin Preparation, Sterile S…
- Feb 18, 2025FDARecall: BD Alaris Systems Manager , REF 9601 Infusion Safety Management Software
- Feb 18, 2025FDARecall: BD Care Coordination Engine (CCE) Infusion Adapter, Safety Management Software
- Feb 19, 2025FDAFDA device clearance: Phasix ST Umbilical Hernia Patch
- Feb 27, 2025FDAFDA device clearance: PIVO Pro Needle-free Blood Collection Device
- Mar 6, 2025FDAFDA device clearance: BD Phoenix Automated Microbiology System
- Mar 11, 2025FDARecall: BD 4 Fr Single-Lumen PowerPICC Catheters, REF: 3174155, CK000540, 3174118, CK000483, 3174335, 3174355, CK000196, 9174118, CK000955, 3174135, CK000617, CK000839…
- Mar 11, 2025FDARecall: BD Pyxis" MedBank" Mini and BD Pyxis" MedBank" Tower, BD Pyxis" MedFlex, BD Pyxis" MedBank" MedPass are automated dispensing cabinets (ADC) intended to securel…
- Mar 11, 2025FDARecall: BD Pyxis MedBank CUBIE Replenishment Station Product / Material ID BD PYXIS MEDBANK TWR MN CR-10HH-2FM-P / 155141-01 BD PYXIS MEDBANK TWR MN CR-10HH-2FH-P / 15…
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Becton Dickinson
For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.
Other recent filings by David Shan, EVP and Chief ISC Officer
The full history of David Shan, EVP and Chief ISC Officer is on the profile page.
How this filing works
Other disclosures at Becton Dickinson
- SEC Form 4Sep 30, 2026
- SEC Form 144Sep 28, 2026
- SEC Form 4Aug 27, 2026
- SEC Form 13F-HRAug 18, 2026
- SEC Form 4Aug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its BDX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
